MAC
CRSP icon

Mason & Associates (California)’s CRISPR Therapeutics CRSP Stock Holding History

Mason & Associates (California)’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$287K Hold
5,900
– – 0.07% 102
2025
Q1 		$201K Buy
+5,900
New +$201K 0.05% 112